Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Long Term Debt Summary of Devyser Diagnostics AB (publ)

  • Devyser Diagnostics AB (publ)'s latest annual long term debt in 2023 was 600 Thousand SEK , up 8.11% from previous year.
  • Devyser Diagnostics AB (publ)'s latest quarterly long term debt in 2024 Q2 was 400 Thousand SEK , down 0.0% from previous quarter.
  • Devyser Diagnostics AB (publ) reported annual long term debt of 555 Thousand SEK in 2022, down -94.43% from previous year.
  • Devyser Diagnostics AB (publ) reported annual long term debt of 9.96 Million SEK in 2021, up 135.93% from previous year.
  • Devyser Diagnostics AB (publ) reported quarterly long term debt of 400 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.
  • Devyser Diagnostics AB (publ) reported quarterly long term debt of 400 Thousand SEK for 2024 Q1, down -33.33% from previous quarter.

Annual Long Term Debt Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Long Term Debt of Devyser Diagnostics AB (publ) (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 600 Thousand SEK 8.11%
2022 555 Thousand SEK -94.43%
2021 9.96 Million SEK 135.93%
2020 4.22 Million SEK -43.76%
2019 7.5 Million SEK -0.74%
2018 7.56 Million SEK 0.0%

Peer Long Term Debt Comparison of Devyser Diagnostics AB (publ)

Name Long Term Debt Long Term Debt Difference
AroCell AB (publ) - SEK -Infinity%
Immunovia AB (publ) 1.78 Million SEK 66.424%
Prostatype Genomics AB (publ) 67 Thousand SEK -795.522%
SenzaGen AB 1.67 Million SEK 64.136%
Spermosens AB 230 Thousand SEK -160.87%